6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nearly 11% of youth with Autism Spectrum Disorder (ASD) undergo psychiatric hospitalization, and 65% are treated with psychotropic medication. Here we characterize psychotropic medication usage in subjects enrolled in the Autism Inpatient Collection. Participant psychotropic medication usage rates topped 90% at admission and discharge, though there was a decline at 2-month follow-up. Antipsychotics, ADHD medications, and sleep aids were the most commonly reported classes of medications. The impact of age, gender, and non-verbal IQ on medication usage rates was minimal, though age and IQ may play a role in prescribing practices. Future work is indicated to explore medication usage trends, the impact of clinical factors on medication use rates, and the safety of psychotropic medications in youth with ASD.

          Related collections

          Author and article information

          Journal
          J Autism Dev Disord
          Journal of autism and developmental disorders
          Springer Nature
          1573-3432
          0162-3257
          May 17 2017
          Affiliations
          [1 ] Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Ave MLC 4002, Cincinnati, OH, 45229, USA. logan.wink@cchmc.org.
          [2 ] Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Ave MLC 4002, Cincinnati, OH, 45229, USA.
          [3 ] Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave MLC 4002, Cincinnati, OH, 45229, USA.
          [4 ] Maine Medical Center Research Institute, Tufts University School of Medicine, 509 Forest Avenue, Portland, ME, 04101, USA.
          [5 ] Emma Pendleton Bradley Hospital, Rhode Island Consortium for Autism Research and Treatment (RI-CART), and the Hassenfeld Child Health Innovation Institute, Alpert Medical School of Brown University, 1011 Veterans Memorial Pkwy., East Providence, RI, 02915, USA.
          [6 ] Sheppard Pratt Health System, University of Maryland School of Medicine, 6501 N. Charles Street, Baltimore, MD, 21204, USA.
          [7 ] Maine Medical Center Research Institute, Spring Harbor Hospital, Tufts University School of Medicine, 123 Andover Road, Westbrook, ME, 04092, USA.
          Article
          10.1007/s10803-017-3153-x
          10.1007/s10803-017-3153-x
          28516426
          93419fb2-9a54-4478-b246-3a066e089397
          History

          Antipsychotics,Autism,Autism Spectrum Disorder,Medication,Psychiatric hospitalization

          Comments

          Comment on this article